Skip to main content

Table 1 Time-course changes of biological data in the index case

From: Transient hypertriglyceridemia: a common finding during Epstein-Barr virus-induced infectious mononucleosis

Day/ month WBC count
(/mm3)
Lymphocyte count
(%)
Bilirubin (mg/dL) ALT
(IU/L)
Triglycerides
(mg/dL)
Total
cholesterol
(mg/dL)
HDL-C (mg/dL) LDL-C (mg/dL) VLDL-C (mg/dL) Lp(a)-C (mg/dL) IgM-VCA IgG-VCA Anti-EBNA
23/1 10,240 67 9.9 207 360 ND ND ND ND ND (+) (-) (-)
27/1 6300 73 7.1 183 367 697 18 583 93 3 ND ND ND
05/2 7420 59 3.8 143 1492 610 31 277 299 0 ND ND ND
11/2 6940 47 2.9 155 302 455 26 328 96 0 ND ND ND
24/2 7790 35 1.5 65 175 227 ND ND ND ND ND ND ND
27/3 6410 36 0.5 30 114 205 ND ND ND ND ND ND ND
16/4 7520 37 0.5 62 193 216 39 134 43 2 (+) (+) (-)
03/6 6000 38 0.3 36 147 242 ND ND ND ND (+/-) (+) (-)
04/8 8020 37 0.5 25 178 211 34 133 44 2 (-) (+) (+)
  1. Cells counts were performed in venous blood. Biochemical determinations and microbiological studies were performed in serum
  2. WBC, white blood cell count. ALT, alanine aminotransferase. VCA, Epstein-Barr virus capsid antigen. EBNA, Epstein-Barr virus nuclear antigen. HDL-C, high-density lipoprotein cholesterol. LDL-C, low-density lipoprotein cholesterol. VLDL-C, very low-density lipoprotein cholesterol. Lp(a)-C, lipoprotein-A cholesterol. Cholesterol fractions [HDL-C, LDL-C, VLDL-C, and Lp(a)-C] were measured by agarose gel electrophoresis. ND, no data available
  3. (+), positive. (-), negative. (+/-), indeterminate value
  4. The patient was treated with fenofibrate (600 mg bid, po) from 05/2 to 27/3